The UK-hosted Global Vaccine Summit heralds a new era of global health collaboration as world leaders show overwhelming commitment to equitable immunisation coverage and global health security in the face of the COVID-19 pandemic.

Pledging announcements

On the eve of the Global Vaccine Summit 2020, five manufacturers commit to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world.

The commitments build on the potency of public private partnerships, which have contributed to Gavi’s success.

Contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.

Pledge follows €120 million in direct funding to Gavi Italy announced at last month’s Coronavirus Global Response pledging conference.

Gavi receives US$ 5 million from the Rockefeller Foundation to support health workers facing COVID-19 pandemic 

UPS partnership with Gavi builds on successful efforts to expand and improve vaccine delivery in Uganda and some of the world’s most underserved communities.

New funding for Gavi to support lower-income countries’ response to the COVID-19 pandemic, including supporting health systems.

Funding will support the response to the COVID-19 pandemic in lower-income countries as well as the vaccination of thousands of children in vulnerable Pacific nations.

Canada’s contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.

Funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.

Funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.

The funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.

Funding will help Gavi protect the most vulnerable, particularly children, against a range of infectious diseases.

Funding will support Gavi’s response to COVID-19 along with efforts to vaccinate 300 million children across the developing world, saving up to 8 million lives.

Short video platform pledges to support Gavi’s life-saving immunisation programmes and future deployment of COVID-19 vaccines.

Pledge follows G20 commitment to provide immediate resources to Gavi.

Cash donation supports the Alliance’s response to COVID-19 and helps protect the world against new outbreaks of other infectious diseases.

  • Thank you Norway
  • Thank you UK
  • Thank you Canada
  • Thank you Spain
  • Thank you Japan
  • Thank you Italy
  • Thank you Ireland
  • Thank you New Zealand
  • Thank you Greece
  • Thank you Switzerland
  • Thank you TikTok

 

Messages of support

 

 

Gavi champions and voices of support

  • H.E. Sahle-Work Zewde President of Ethiopia
  • H.E. Uhuru Kenyatta President of KenyaH.E. Sahle-Work Zewde President of Ethiopia
  • H.E. Nana Addo Dankwa Akufo-Addo President, Republic of Ghana
  • S.E.M. Issoufou Mahamadou Président de la République du Niger, Chef de l'Etat
  • H.E. Faustin-Archange Touadéra Président de la République centrafricaine

Global Vaccine Summit 2020

2020 marks an important milestone for Gavi to build on the historic gains made since its creation, 20 years ago. This meeting will bring together global leaders from the public and private sectors.

Read more

It follows Gavi’s second successful pledging conference in Berlin hosted in January 2015 by Chancellor Angela Markel under the auspices of Germany’s G7 Presidency, which raised US$ 7.5 billion for the 2016-2020 period.

The UK and Gavi

The UK is one of Gavi’s six original donors and one of two donor countries that support Gavi through all three funding channels (direct grants, IFFIm and AMC).

For the 2000-2020 period, the UK has committed USD 3 billion in direct funding (2000-2020), of which USD 61 million (GBP 50 million) is allocated to the Matching Fund (2011-2015). Moreover, the UK has pledged USD 2.7 billion in IFFIm (for 2007-2029), USD 485 million to the pneumococcal AMC (for 2010-2018) and USD 40 million to IPV (for 2013-2018).

In 2011, Prime Minister David Cameron hosted Gavi’s donor pledging conference in London.

The 2021-2025 Investment Opportunity

Gavi's Investment Opportunity was launched at a high-level meeting hosted by the Government of Japan on the occasion of the 7th Tokyo International Conference on African Development (TICAD) in Yokohama on 30 August 2019. Prime Minister Abe announced Gavi’s Investment Opportunity launch in his opening speech at TICAD.

Read more

The Investment Opportunity highlighted that more children have been immunised with a wider range of vaccines than at any time in history.  With support from Gavi’s partners and bold commitments from donors, implementing countries and the private sector, the Alliance is poised to bring about even greater impact in the coming five years. Through its innovative approach to development, including innovative finance, the Alliance will help countries PREVENT disease with vaccines in order to PROTECT the next generation and ensure countries can PROSPER. By working together, and with enough support, we can achieve more impact, more efficiently and at a lower cost to donors than ever before.

With countries squarely in the driving seat, Gavi will help foster long-term sustainability and vaccine supply security through its unique transition model and market shaping efforts. Our work together – leveraging donor financing, empowering countries, shaping sustainable markets – will:

  • Allow us to achieve the Alliance’s goals and reach a further 300 million children between 2021 and 2025 and, through the full protection of the broadest vaccine portfolio in history, save an additional 7–8 million lives.
  • Catalyse country contributions of US$ 3.6 billion in domestic co-financing and self-funded vaccine programmes.
  • Contribute to a further US$ 80–100 billion in economic benefits.
  • Enhance the competitiveness and supply security of at least five Gavi-supported vaccine markets

In order to deliver on its ambitious plans and deliver the most comprehensive package of protection in Alliance history, Gavi will need at least US$ 7.4 billion in additional resources for the period 2021–2025.

With countries squarely in the driving seat, Gavi will help foster long-term sustainability and vaccine supply security through its unique transition model and market shaping efforts. Our work together – leveraging donor financing, empowering countries, shaping sustainable markets – will:

  • Allow us to achieve the Alliance’s goals and reach a further 300 million children between 2021 and 2025 and, through the full protection of the broadest vaccine portfolio in history, save an additional 7–8 million lives.
  • Catalyse country contributions of US$ 3.6 billion in domestic co-financing and self-funded vaccine programmes.
  • Contribute to a further US$ 80–100 billion in economic benefits.
  • Enhance the competitiveness and supply security of at least five Gavi-supported vaccine markets
Figure 1: Cumulative vaccination and lives saved by 2025

Pivotal moment

This ambitious programme is realistic and within reach. Without critical funding however, we run the risk of losing the momentum of our hard-fought gains and even backsliding.

The next strategic period will be a critical one for Gavi and represents a turning point in our history. With the political will and investment of countries, the ingenuity of Alliance partners, and the generosity of its donors, we can achieve a world where we can make vaccines work for all.

Figure 2: Leveraging country financing for Gavi-supported vaccines

Prevent, Protect, Prosper

This is the time to build on the unprecedented gains from Gavi’s past investments and historical achievements to bring about continued acceleration of immunisation.

Its collaborative model brings the best resources in global health and immunisation together and can continue to use innovation to achieve even stronger impact. Now is not the time for complacency. Now is the time for renewed commitment to help countries prevent disease, protect their communities and, above all, prosper.

Featured content

Scientists around the world are working at an unprecedented pace to test different types of vaccines that could help to stop the spread of COVID-19.

Global Handwashing Day and the ongoing spread of COVID-19 is a timely reminder about the importance of handwashing with soap as an effective and affordable way to stay healthy.

As the pandemic unfolded around the world, hand sanitizer and handwashing stations became as in-demand as toilet paper.

These global efforts are increasingly urgent as the economic impact of the COVID-19 pandemic continues to put millions of lives at risk from famine and malnutrition.

People who have had COVID-19 can develop an immune response that normally protects people from recurrent infection. But now that reinfections of COVID-19 have been recorded, what does that mean for our ability to fight the virus?

European Commission Civil Protection and Humanitarian Aid Operations (ECHO) humanitarian air bridge made it possible

Preventing and controlling infectious disease is possible with dedication of health workers, multi-stakeholder collaboration and equitable access to vaccines. Africa’s wild polio-free certification, which took decades of collaborative effort, is…

Just over six months since COVID-19 was declared a pandemic, what do we know about this new coronavirus?

For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.

Emergency use procedures are designed to make potentially life-saving medical products available as quickly as possible during health emergencies. A record number have been granted since the arrival of COVID-19 pandemic, but what does this mean…

Polio, a contagious disease caused by the poliomyelitis virus is transmitted primarily when stool from someone infected contaminates foods, drinks or water sources. It invades the nervous system and could, in a matter of hours, lead to complete…

Vaccines are designed to trigger an immune response to pathogens we’ve never encountered before. But how does it feel to be one of the first humans to encounter a new vaccine? British communications consultant Heather Macdonald-Tait explains what…

In a matter of months, the COVID-19 pandemic has devastated the global economy. Now a new study looks at how this economic shock is impacting sovereign debt levels of Gavi-supported countries.

Africa has not been as hard hit by the COVID-19 pandemic as predicted. Here, we talk to Professor Salim Abdool Karim, the head of South Africa's Ministerial Advisory Committee on COVID-19 to find out why and what the future might hold.

Vaccines save lives by protecting children and adults from diseases. COVID-19 pandemic is a clear example of what a world without vaccines could look like. Governments should ensure that delivery of essential services such as vaccines remains a…

Throughout the 2016–2020 strategic period, the Vaccine Alliance has worked with countries to improve data quality. From GIS to SMS, new tech and tools aim to reach more people with life-saving immunisation.

To bring countries on a trajectory towards financial sustainability, and to empower them to take ownership
of their vaccination programmes, Gavi has pioneered an approach to co-financing and transition.

With only 542 global cases in 2019, polio is a distant memory in most parts of the world. However, this highly contagious disease could spread rapidly in communities with limited access to vaccines, health care and sanitation – a risk greatly…

Her own healthy baby son is how Ugandan nurse Maureen Wandawa demonstrates the benefits of immunization. Working together to build confidence in, and access to, vaccines for all who need them is one way we can #UniteforHealth to keep us all safer…

Gavi's partnership with telecoms provider Orange and the Ministry of Health overcomes barriers to childhood immunisation through tailored, tested technology.

Last updated: 13 Aug 2020

Subscribe to our newsletter